●] Shares of Common Stock Xeris Pharmaceuticals, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • February 11th, 2019 • Xeris Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 11th, 2019 Company Industry Jurisdiction
XERIS PHARMACEUTICALS, INC. EMPLOYMENT AGREEMENTEmployment Agreement • February 11th, 2019 • Xeris Pharmaceuticals Inc • Pharmaceutical preparations • Illinois
Contract Type FiledFebruary 11th, 2019 Company Industry JurisdictionThis Employment Agreement (“Agreement”) is made as of the 10th day of June, 2018, between Xeris Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Beth Hecht (the “Executive”) and is effective as of the closing of the Company’s first underwritten public offering of its equity securities pursuant to an effective registration statement under the Securities Act of 1933, as amended (the “Effective Date”).
FIRST AMENDMENT TO OFFICE LEASE AGREEMENTOffice Lease Agreement • February 11th, 2019 • Xeris Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledFebruary 11th, 2019 Company Industry
FIRST AMENDMENT TO THE EMPLOYMENT AGREEMENT BETWEEN BETH P. HECHT (“EXECUTIVE”) AND XERIS PHARMACEUTICALS, INC. (“COMPANY”)Employment Agreement • February 11th, 2019 • Xeris Pharmaceuticals Inc • Pharmaceutical preparations
Contract Type FiledFebruary 11th, 2019 Company IndustryTHIS FIRST AMENDMENT (this “Amendment”) to the Employment Agreement dated June 10, 2018 between Executive and the Company (the “Employment Agreement”) is made effective as of January 1, 2019. Capitalized terms used herein, and not otherwise defined shall have the meanings ascribed thereto in the Employment Agreement.